- Home
- MQ vs SRPT Comparison
MQ vs SRPT Comparison
Compare MQ & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- SRPT
- Stock Information
- Founded
- MQ 2010
- SRPT 1980
- Country
- MQ United States
- SRPT United States
- Employees
- MQ N/A
- SRPT N/A
- Industry
- MQ Computer Software: Prepackaged Software
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- MQ Technology
- SRPT Health Care
- Exchange
- MQ Nasdaq
- SRPT Nasdaq
- Market Cap
- MQ 1.9B
- SRPT 1.7B
- IPO Year
- MQ 2021
- SRPT 1997
- Fundamental
- Price
- MQ $5.77
- SRPT $13.53
- Analyst Decision
- MQ Hold
- SRPT Buy
- Analyst Count
- MQ 13
- SRPT 25
- Target Price
- MQ $5.35
- SRPT $59.43
- AVG Volume (30 Days)
- MQ 5.8M
- SRPT 10.2M
- Earning Date
- MQ 08-06-2025
- SRPT 08-06-2025
- Dividend Yield
- MQ N/A
- SRPT N/A
- EPS Growth
- MQ N/A
- SRPT N/A
- EPS
- MQ 0.11
- SRPT N/A
- Revenue
- MQ $528,100,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- MQ $18.09
- SRPT $19.93
- Revenue Next Year
- MQ $21.72
- SRPT N/A
- P/E Ratio
- MQ $53.77
- SRPT N/A
- Revenue Growth
- MQ N/A
- SRPT 59.15
- 52 Week Low
- MQ $3.37
- SRPT $12.85
- 52 Week High
- MQ $6.01
- SRPT $150.48
- Technical
- Relative Strength Index (RSI)
- MQ 59.96
- SRPT 37.36
- Support Level
- MQ $5.70
- SRPT $17.84
- Resistance Level
- MQ $6.01
- SRPT $22.86
- Average True Range (ATR)
- MQ 0.13
- SRPT 1.24
- MACD
- MQ -0.03
- SRPT 1.07
- Stochastic Oscillator
- MQ 58.73
- SRPT 23.83
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.